CLINICAL ASPECTS OF 3 NEW PROGESTOGENS - DESOGESTREL, GESTODENE, AND NORGESTIMATE

被引：26

作者：

CHEZ, RA

机构：

来源：

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 1989年 / 160卷 / 05期

关键词：

D O I：

10.1016/S0002-9378(89)80016-X

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

引用

页码：1296 / 1300

页数：5

共 29 条

[21] FIBRINOPEPTIDE A PLASMA-LEVELS DURING LOW-ESTROGEN ORAL-CONTRACEPTIVE TREATMENT [J].

MELIS, GB ;

FRUZZETTI, F ;

PAOLETTI, AM ;

CARMASSI, F ;

FIORETTI, P .

CONTRACEPTION, 1984, 30 (06) :575-583

[22]

Rabe T, 1987, Int J Fertil, V32 Suppl, P29

[23]

RAKOCZI I, 1985, DRUG RES, V35, P630

[24]

Rubio-Lotvin B, 1978, Acta Eur Fertil, V9, P1

[25] NEW PROGESTOGENS IN ORAL-CONTRACEPTIVES [J].

RUNNEBAUM, B ;

RABE, T .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1987, 157 (04) :1059-1063

[26]

SCHIJF CP, 1984, ADV FERTILITY CONTRO, P61

[27] TRIPHASIC ORAL CONTRACEPTION - METABOLIC EFFECTS IN NORMAL WOMEN AND THOSE WITH PREVIOUS GESTATIONAL DIABETES [J].

SKOUBY, SO ;

KUHL, C ;

MOLSTEDPEDERSEN, L ;

PETERSEN, K ;

CHRISTENSEN, MS .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1985, 153 (05) :495-500

[28]

SONA J, 1987, INT J FERTIL S, V32, P6

[29]

VANDERVANGE N, 1987, BRIT J OBSTET GYNAEC, V94, P559

← 1 2 3 →